Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Oncy is a Cult Pt. 2

<< Previous

Bullboard Posts

Next >>

Comment by ScootsMcgootson Feb 07, 2024 3:13pm

112 Views

Post# 35868199

RE:RE:RE:Oncy is a Cult Pt. 2

Azz I'll remind you again Canadians are a nationality not a race. And a few lighthearted jokes about Canadians in biotech are more than warranted given the neverending shitshow that is ONCY. But don't fret, the Canadian race will survive this great slight.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023